Literature DB >> 29456150

Antidepressants as antipruritic agents: A review.

Randeep Kaur1, V R Sinha2.   

Abstract

Pruritus is a concomitant symptom of various underlying disorders viz. dermatological, systemic and psychiatric disorders that provoke the person to scratch the skin. Many natural as well as, antipruritic therapies are usually practiced in the treatment of pruritus including general preventive measures, topical therapies such as cooling agents, antihistamines, anesthetics, capsaicin, corticosteroids, immunomodulators and; systemic therapies including administration of antihistamines, opioid antagonists/agonists, antiepileptic drugs/neuroleptics (e.g., gabapentin and pregabalin), antidepressants (e.g., doxepin, amitriptyline, paroxetine, fluvoxamine, sertraline, escitalopram and mirtazapine) (Patel and Yosipovitch, 2010; Reich et al., 2011; Martín and Padilla, 2015; Eskeland et al., 2016). Topical therapies are the mainstay of treatment of delicate and localized pruritus while other systemic drug therapies are used to treat stern and generalized pruritus. The reported antipruritic activity of some antidepressant drugs has intrigued this review to focus on the types of pruritus, pruritus mechanism, the antipruritic mechanism of antidepressants and to comprehend the role of antidepressants in the management of pruritus.
Copyright © 2018 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Antidepressants; IFSI; Itch; Pruritus; Pruritus classification; Topical

Mesh:

Substances:

Year:  2018        PMID: 29456150     DOI: 10.1016/j.euroneuro.2018.01.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  2 in total

Review 1.  Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors.

Authors:  Benjamin C Park; Seungyeon Jung; Steven T Chen; Anna K Dewan; Douglas B Johnson
Journal:  Am J Clin Dermatol       Date:  2022-06-16       Impact factor: 6.233

2.  Mirtazapine for the Treatment of Chronic Pruritus.

Authors:  Raveena Khanna; Emily Boozalis; Micah Belzberg; John G Zampella; Shawn G Kwatra
Journal:  Medicines (Basel)       Date:  2019-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.